You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
M. HAUG Universite Louis Pasteur, Laboratoire de Psychophysi%gie, URA 1295, 7, rue de /'Universite, 67000 Strasbourg, France This varied and impressive volume is a record of the major presentations at the NATO sponsored Advanced Research Workshop on The Development of Sex Differences and Similarities in Behaviour held at the Chateau de Bonas, Gers, France July 14-18, 1992. It is fitting that a meeting evaluating masculine and feminine 'characteristics' was located in the Gascony region immortalised in Alexandre Dumas epic, macho tale of The Three Musketeers. It is even more satisfying that Marc HAUG the French Director (a D' Artagnan equivalent) was ably assisted by a US/French Consortium of three co-Directors (Drs. Richard E. WHALEN, Claude ARON and Kathie L. OLSEN). The ARW also provided opportunities to explore the region around the Chateau, to appreciate the complex history of the area and to sample armagnac and other local gastronomic creations. A lively and varied cultural programme (classics to jazz) was also provided to maintain the interests and enthusiasms of the participants.
First published in 1989. Routledge is an imprint of Taylor & Francis, an informa company.
Includes entries for maps and atlases.
This book is a comprehensive compilation and discussion of research findings on female aggression from anthropology, social psychology, animal research, case studies, and representations in literature. This multidisciplinary approach will address such questions as: 'Are females less aggressive than males?' 'Is female aggressive behavior perhaps quantitatively, different than male aggressive behavior?' The book also discusses patterns of agression, the role of hormones in aggression, cultural differences, and how human aggression differs from aggression within animal species.
Although everybody had and will experience anxiety, its intensity, frequency and characteristics may vary from what can be considered as "normal" to pathological. The development of benzodiazepine as anxiolytics has been a major step firstly in therapeutics and secondly in the understanding of the associated biological mechanisms. Recently, new drugs without secondary effects of benzodiazepines have been developed. The purpose of the book was to take stock of the present knowledge: clinical aspects of pathological anxiety, neurobiological mechanisms associated with stress and anxiety, molecular targets of potent anxiolytic drugs, new issues and directions.
None
None
First multi-year cumulation covers six years: 1965-70.